Insiteverse

$HOOD Q3 earnings drop 11/5 amid wild 449% rally—analysts see $1.2B rev (+90% YoY), $0.61 EPS, fueled by 415% crypto growth & user base up 9.5% YoY to 26.5M. Techs: MACD bullish, RSI ~neutral. Despite gains, the stock closed -7% pre-earnings as valuation (69x P/E) & looming crypto regulation raise caution. Outperforming peers on growth, but near-term volatility is high, let's watch for post-earnings direction.

https://stonksai.us (Register for Beta!)

$HIMS is set to report Q3 earnings on November 3, with Wall Street expecting earnings per share of $0.09 and revenue around $583 million—up 45% year-over-year. Recent launches in hormonal health and enhanced AI capabilities are driving platform expansion, user retention, and margin improvements. Despite short-term volatility, HIMS shows strong growth potential, and holding shares may offer continued upside if results meet expectations. Momentum depends on beating estimates and management’s outlook after the call.

Hims & Hers Health, Inc. Stock Price: Quote, Forecast, Splits & News (HIMS) Get the latest Hims & Hers Health, Inc. stock price (HIMS), historical data, earnings reports, stock split stock split history, analyst ratings, and forecasts from Perplexity Finance.

🚨 $TSLA reports record Q3 revenue of $28.1, but profits dropped sharply, EPS missed, and margin pressure grows. Shares fell ~2% after hours despite strong vehicle sales. Cost headwinds & expiry of EV tax credits shaping investor sentiment. Will TSLA bounce back? Follow us at

Update: In after-hours trading, $DLR is up. The outlook will depend on the earnings call details and analyst updates coming up. Watching price action and guidance closely.

$DLR trades flat near $172, with neutral technical signals and modest volatility. Today's after-hours earnings should show steady growth (EPS $1.78, +6.4% revenue) from AI/cloud expansion. Long term, strong industry demand supports upside, but CapEx and debt are watch risks. Not Financial Advice - Follow us at